Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
UnitedHealth
UNH
|
+$474M |
| 2 |
Linde
LIN
|
+$459M |
| 3 |
Elevance Health
ELV
|
+$377M |
| 4 |
Oracle
ORCL
|
+$374M |
| 5 |
PepsiCo
PEP
|
+$340M |
Top Sells
| 1 |
Baidu
BIDU
|
+$302M |
| 2 |
Cisco
CSCO
|
+$286M |
| 3 |
AbbVie
ABBV
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$210M |
| 5 |
General Motors
GM
|
+$210M |
Sector Composition
| 1 | Technology | 23.58% |
| 2 | Healthcare | 13.98% |
| 3 | Financials | 12.35% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Wabash National
WNC
$457M
| $10.6M | ﹤0.01% |
783,190
+589,060
| +303% | +$8M |
|
1452
Liberty Latin America Class C
LILAK
$1.53B
| $10.6M | ﹤0.01% |
1,364,544
+27,675
| +2% | +$216K |
|
1453
10x Genomics
TXG
$1.57B
| $10.6M | ﹤0.01% |
234,701
+30,784
| +15% | +$1.39M |
|
|
ONEM
1454
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $10.6M | ﹤0.01% |
1,353,273
+565,163
| +72% | +$4.43M |
|
1455
Virtus Investment Partners
VRTS
$1.34B
| $10.6M | ﹤0.01% |
62,034
+8,843
| +17% | +$1.51M |
|
1456
Denali Therapeutics
DNLI
$2.07B
| $10.6M | ﹤0.01% |
360,158
-10,071
| -3% | -$296K |
|
1457
Encore Capital Group
ECPG
$1.02B
| $10.6M | ﹤0.01% |
183,170
+66,940
| +58% | +$3.87M |
|
1458
Herc Holdings
HRI
$4.2B
| $10.6M | ﹤0.01% |
117,247
+20,023
| +21% | +$1.81M |
|
1459
Privia Health
PRVA
$2.8B
| $10.6M | ﹤0.01% |
362,908
+58,253
| +19% | +$1.7M |
|
1460
Matsons
MATX
$3.29B
| $10.6M | ﹤0.01% |
144,835
-10,527
| -7% | -$767K |
|
1461
MarineMax
HZO
$556M
| $10.5M | ﹤0.01% |
291,719
+114,044
| +64% | +$4.12M |
|
1462
Rithm Capital
RITM
$6.57B
| $10.5M | ﹤0.01% |
1,129,735
-16,123
| -1% | -$150K |
|
1463
Armstrong World Industries
AWI
$8.5B
| $10.5M | ﹤0.01% |
140,042
-1,606
| -1% | -$120K |
|
1464
Cohen & Steers
CNS
$3.65B
| $10.5M | ﹤0.01% |
164,610
+12,899
| +9% | +$820K |
|
|
CTIC
1465
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $10.4M | ﹤0.01% |
+1,750,193
| New | +$10.4M |
|
1466
Conduent
CNDT
$445M
| $10.4M | ﹤0.01% |
2,413,513
+193,636
| +9% | +$837K |
|
1467
Red Rock Resorts
RRR
$3.65B
| $10.4M | ﹤0.01% |
312,171
-183,905
| -37% | -$6.14M |
|
1468
Maravai LifeSciences
MRVI
$386M
| $10.4M | ﹤0.01% |
365,592
+4,365
| +1% | +$124K |
|
|
EQC
1469
DELISTED
Equity Commonwealth
EQC
| $10.4M | ﹤0.01% |
377,012
-26,231
| -7% | -$722K |
|
|
CTEV
1470
Claritev Corporation
CTEV
$1.01B
| $10.4M | ﹤0.01% |
47,147
-13,390
| -22% | -$2.94M |
|
1471
Enova International
ENVA
$2.88B
| $10.3M | ﹤0.01% |
358,981
-5,332
| -1% | -$154K |
|
1472
WesBanco
WSBC
$3.03B
| $10.3M | ﹤0.01% |
325,524
-105,066
| -24% | -$3.33M |
|
1473
CNO Financial Group
CNO
$3.8B
| $10.3M | ﹤0.01% |
569,720
-23,382
| -4% | -$423K |
|
1474
Onto Innovation
ONTO
$5.44B
| $10.3M | ﹤0.01% |
147,790
-21,935
| -13% | -$1.53M |
|
1475
Skechers
SKX
| $10.3M | ﹤0.01% |
289,666
+21,223
| +8% | +$755K |
|